This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Diabetic Macular Edema
Information about Diabetic Macular Edema: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Diabetic Macular Edema
Most recent studies have shown that Diabetic Macular Edema shares some biological mechanisms with age-related-macular-degeneration, blind-vision, cataract, clinically-significant-macular-edema, diabetes-mellitus, diabetes-mellitus-insulin-dependent, diabetes-mellitus-non-insulin-dependent, diabetic-retinopathy, edema, intraocular-pressure-disorder, macular-edema-cystoid, macular-retinal-edema, macule, pathologic-neovascularization, proliferative-diabetic-retinopathy, retinal-detachment, retinal-diseases, retinal-vein-occlusion, visual-impairment.
Among the many pathways, these few ones have gauged particular interests from scientists studying Diabetic Macular Edema, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Death, Cell Migration, Cell Proliferation, Coagulation, Dehiscence, Endothelial Cell Proliferation, Glycosylation, Inflammatory Response, Ion Transport, Localization, Pathogenesis, Reflex, Secretion, Segmentation, Transport, Vasoconstriction, Vasodilation, Wound Healing
Quite a number of genes have been found to play important roles in Diabetic Macular Edema, such as CALCR, CALR, CCL2, COX5A, EPO, FANCA, FXN, IL6, INS, PLXNA2, PRNP, PRRT2, RANGAP1, RPE, SERPINF1, SLC17A5, SLC6A8, TNF, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.